131 related articles for article (PubMed ID: 2097310)
1. The study of ocular hypotensive effect of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
Lu DW; Chiang CH; Kao KD; Wen LY
J Ocul Pharmacol; 1990; 6(4):271-8. PubMed ID: 2097310
[TBL] [Abstract][Full Text] [Related]
2. Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor.
Lewis RA; Schoenwald RD; Eller MG; Barfknecht CF; Phelps CD
Arch Ophthalmol; 1984 Dec; 102(12):1821-4. PubMed ID: 6548907
[TBL] [Abstract][Full Text] [Related]
3. Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
Kao KD; Lu DW; Chiang CH; Huang HS
J Ocul Pharmacol; 1990; 6(4):313-20. PubMed ID: 2097315
[TBL] [Abstract][Full Text] [Related]
4. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
[TBL] [Abstract][Full Text] [Related]
5. Aminozolamide suspension: the role of the vehicle in a topical carbonic anhydrase inhibitor.
Lewis RA; Schoenwald RD; Barfknecht CF
J Ocul Pharmacol; 1988; 4(3):215-9. PubMed ID: 3198983
[TBL] [Abstract][Full Text] [Related]
6. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Schwam H; Baldwin JJ; Christy ME; Ponticello GS
J Ocul Pharmacol; 1990; 6(1):9-22. PubMed ID: 2362161
[TBL] [Abstract][Full Text] [Related]
7. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Schmitt C; Viader MP; Conquet P; Smith RL; Share NN; Stone CA
J Pharmacol Exp Ther; 1985 Feb; 232(2):534-40. PubMed ID: 3838190
[TBL] [Abstract][Full Text] [Related]
8. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
Sugrue MF; Mallorga P; Schwam H; Baldwin JJ; Ponticello GS
Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
[TBL] [Abstract][Full Text] [Related]
9. Topical carbonic anhydrase inhibitors.
Kass MA
Am J Ophthalmol; 1989 Mar; 107(3):280-2. PubMed ID: 2923154
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
Sharir M; Pierce WM; Chen D; Zimmerman TJ
Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
[TBL] [Abstract][Full Text] [Related]
11. Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension.
Lewis RA; Schoenwald RD; Barfknecht CF; Phelps CD
Arch Ophthalmol; 1986 Jun; 104(6):842-4. PubMed ID: 3521557
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles.
Gelatt KN; Gum G; Williams LW; Gwin RM
Am J Vet Res; 1979 Mar; 40(3):334-45. PubMed ID: 475084
[TBL] [Abstract][Full Text] [Related]
13. Topically active carbonic anhydrase inhibitors. 1. O-acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide.
Woltersdorf OW; Schwam H; Bicking JB; Brown SL; deSolms SJ; Fishman DR; Graham SL; Gautheron PD; Hoffman JM; Larson RD
J Med Chem; 1989 Nov; 32(11):2486-92. PubMed ID: 2810337
[TBL] [Abstract][Full Text] [Related]
14. Studies of topical carbonic anhydrase inhibitors: ocular hypotensive effect of thiadiazole derivatives.
Chiang CH; Lee AR; Lin CH
J Ocul Pharmacol; 1993; 9(2):109-15. PubMed ID: 8345284
[TBL] [Abstract][Full Text] [Related]
15. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
Brechue WF; Maren TH
Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
[TBL] [Abstract][Full Text] [Related]
16. Relations among IOP reduction, ocular disposition and pharmacology of the carbonic anhydrase inhibitor ethoxzolamide.
Maren TH; Brechue WF; Bar-Ilan A
Exp Eye Res; 1992 Jul; 55(1):73-9. PubMed ID: 1397133
[TBL] [Abstract][Full Text] [Related]
17. Ocular hypotensive activity and disposition of the topical carbonic anhydrase inhibitor 6-hydroxy-benzo[b]thiophene-2-sulfonamide, L-650,719, in the rabbit.
Bar-Ilan A; Pessah NI; Maren TH
J Ocul Pharmacol; 1989; 5(2):99-110. PubMed ID: 2754300
[TBL] [Abstract][Full Text] [Related]
18. The effects of topical and general anesthesia on ocular drug levels and intraocular pressure lowering activity of topically applied carbonic anhydrase inhibitors.
Bar-Ilan A; Pessah NI
J Ocul Pharmacol; 1988; 4(1):1-12. PubMed ID: 3171330
[TBL] [Abstract][Full Text] [Related]
19. N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressure.
Duffel MW; Ing IS; Segarra TM; Dixson JA; Barfknecht CF; Schoenwald RD
J Med Chem; 1986 Aug; 29(8):1488-94. PubMed ID: 3735316
[TBL] [Abstract][Full Text] [Related]
20. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151.
Bar-Ilan A; Pessah NI; Maren TH
J Ocul Pharmacol; 1986; 2(2):109-20. PubMed ID: 3503100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
